Related Experiment Video
Updated: Mar 15, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Association between neuropeptide Y receptor Y2 promoter variant rs6857715 and major depressive disorder
Jens Treutlein1, Jana Strohmaier, Josef Frank
1aDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Heidelberg bInstitute of Human Genetics, University of Bonn, Bonn, Germany cDepartment of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany d Department of Child and Adolescent Psychiatry, University Psychiatric Hospital, Bern, Switzerland eDepartment of Biomedicine, Division of Medical Genetics, University of Basel, Basel, Switzerland.
Abstract:
Stress increases the risk for major depressive disorder (MDD), overeating, and alcohol dependence (AD). The neuropeptide Y system is one of the best-known modulators of the stress response, and some of its effects are mediated through the neuropeptide Y receptor Y2 (NPY2R). The functional NPY2R variant rs6857715 (C-599T) has been implicated in both obesity and AD, but with opposing alleles. The present study explored whether rs6857715 is also associated with MDD. Analysis of the overall sample (595 MDD cases; 1295 controls) showed an association with the AD risk allele C [P=0.020, odds ratio (OR) (C-allele)=1.18]. The association remained significant after excluding MDD patients with AD/alcohol abuse [P=0.038, OR (C-allele)=1.18]; increased weight/appetite [P=0.006, OR (C-allele)=1.23]; or both [P=0.008, OR (C-allele)=1.25]. The present findings suggest that the NPY2R rs6857715 C-allele makes a genuine contribution toward MDD.
Related Concept Videos
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
G-protein Coupled Receptors
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Depressive Disorders: MDD and Dysthymia
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

